| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |